Table I.
Patient demographics and clinical characteristics (n=107) based on AKI.
| Clinicopathological characteristics | Non-AKI (n=78) | AKI (n=29) | P-value | χ2 value | Total (n=107) |
|---|---|---|---|---|---|
| Sex, % male | 42 (53.8) | 23 (79.3) | 0.025a | 5.719 | 65 (60.7) |
| Age, years | 69.70±5.90 | 69.90±5.83 | 0.881 | 0.150 | 69.76±4.773 |
| Comorbidities, n (%) | |||||
| Hypertension | 36 (46.1) | 22 (75.9) | 0.008a | 7.516 | 58 (54.2) |
| Diabetes | 21 (26.9) | 8 (27.6) | 1.000 | 0.005 | 29 (27.1) |
| Immune diseases | 7 (8.97) | 6 (20.7) | 0.179 | 2.718 | 13 (12.1) |
| Cardiovascular disease | 40 (51.3) | 24 (82.7) | 0.004a | 8.714 | 64 (59.8) |
| Liver disease | 3 (3.85) | 2 (6.90) | 0.611 | 0.022 | 5 (4.67) |
| COPD | 16 (20.5) | 3 (10.3) | 0.268 | 0.881 | 19 (17.7) |
| Noradrenaline use, % | 32 (41.0) | 23 (79.3) | ≤0.001a | 12.404 | 55 (51.4) |
| Mechanical ventilation, n (%) | 45 (57.7) | 23 (79.3) | 0.044a | 4.265 | 68 (63.5) |
| SOFA | 5.756±2.960 | 9.448±3.611 | ≤0.001a | 5.395 | 6.757±3.10 |
| APACHE II | 15.83±5.86 | 21.69±7.04 | ≤0.001a | 4.344 | 17.42±2.28 |
| Mortality | 24 (30.8) | 16 (89.6) | 0.026a | 5.378 | 40 (37.4) |
| Need for dialysis, n (%) | 2 (2.56) | 17 (58.6) | ≤0.001a | 45.488 | 19 (17.8) |
AKI, acute kidney injury; COPD, chronic obstructive pulmonary disease; APACHE, Acute Physiology And Chronic Health Evaluation; SOFA, sequential organ failure assessment. Values are expressed as the mean ± standard deviation or the median and interquartile range.
a
P<0.05.